Award
Delivery Order #SPE2D326F6292
Pfizer Inc. Receives Delivery Order for Cyklokapron Injection
Buyer
Defense Logistics Agency
Award Amount
$134.76
Ceiling
$134.76
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2D326F6292
NAICS
325412
This award represents a delivery order contract modification under an existing indefinite delivery vehicle agreement with Pfizer Inc., a leading global pharmaceutical company. The contract procures Cyklokapron injection, a medication typically used to control bleeding, delivered in a specific dose and volume. The significance of this contract lies in its support of ongoing military health operations, ensuring essential pharmaceuticals are available to maintain troop readiness and medical care. The scope involves procurement and timely delivery of the requested pharmaceutical product to a specified location in New York City within a short timeframe. This delivery order was awarded as part of the larger IDV contract originally competitively bid, emphasizing the continuing relationship between the Department of Defense and Pfizer for critical medical supplies. The performance period for this order is brief, covering several days, illustrating prompt fulfillment of urgent supply needs.
Description
4570894828!CYKLOKAPRON 1,000 MG/10 ML VL 10ML